Hemolysis induced cross-matching difficulty with intravenous immunoglobulin: a case report

BACKGROUND: Intravenous immunoglobulin is one of the most common modalities of treatment for Guillain–Barré syndrome. Although minor complications are easily preventable with pre-medications, rare complications like hemolysis occur at unexpected times and carry risks of repeated transfusions. A comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Achyut, Aryal, Diptesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120083/
https://www.ncbi.nlm.nih.gov/pubmed/30173672
http://dx.doi.org/10.1186/s13256-018-1774-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120083/
https://www.ncbi.nlm.nih.gov/pubmed/30173672
http://dx.doi.org/10.1186/s13256-018-1774-0

Ejemplares similares